For citations:
Krylova S.G., Pove’teva T.N., Lopatina K.A., Nesterova Yu.V., Zueva E.P., Afanas’eva O.G., Kulpin P.V., Kiseleva E.A., Suslov N.I., Kulagina D.A., Sysolyatin S.V., Zhdanov V.V. Risk of developing drug abuse in administration of a new hexaazaisowurtzitane derivative-based analgesic (experimental study). Bulletin of Siberian Medicine. 2022;21(1):54-62. https://doi.org/10.20538/1682-0363-2022-1-54-62
Email this article 